|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 36.03 USD | -0.22% |
|
+13.30% | +13.09% |
| Capitalization | 571.91Cr 493.05Cr 458.99Cr 427.3Cr 795.59Cr 52TCr 855.98Cr 5.28TCr 2.08TCr 25TCr 2.14TCr 2.1TCr 90TCr | P/E ratio 2025 * |
28.2x | P/E ratio 2026 * | 24.4x |
|---|---|---|---|---|---|
| Enterprise value | 645.47Cr 556.46Cr 518.02Cr 482.26Cr 897.91Cr 59TCr 966.07Cr 5.96TCr 2.35TCr 28TCr 2.42TCr 2.37TCr 1,02000Cr | EV / Sales 2025 * |
1.14x | EV / Sales 2026 * | 1.04x |
| Free-Float |
92.06% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Option Care Health, Inc.
| 1 day | -0.22% | ||
| 1 week | +13.30% | ||
| Current month | +13.09% | ||
| 1 month | +9.41% | ||
| 3 months | +32.95% | ||
| 6 months | +18.58% | ||
| Current year | +13.09% |
| 1 week | 31.54 |  | 36.32 |
| 1 month | 30.86 | | 36.32 |
| Current year | 30.86 | | 36.32 |
| 1 year | 24.24 | | 36.32 |
| 3 years | 21.39 | | 36.32 |
| 5 years | 16.02 | | 36.32 |
| 10 years | 5.74 | | 36.32 |
| Manager | Title | Age | Since |
|---|---|---|---|
John Rademacher
CEO | Chief Executive Officer | 59 | 06/08/2019 |
Meenal Sethna
DFI | Director of Finance/CFO | 57 | 01/10/2025 |
Femi Adewunmi
CTO | Chief Tech/Sci/R&D Officer | 52 | 01/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
John Rademacher
BRD | Director/Board Member | 59 | 06/08/2019 |
Timothy Sullivan
BRD | Director/Board Member | 68 | 07/08/2019 |
Elizabeth Betten
BRD | Director/Board Member | 45 | 07/08/2019 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.22% | +13.30% | +22.89% | +24.50% | 571.91Cr | |
| -3.00% | -0.59% | +51.66% | +81.28% | 11TCr | |
| -3.39% | -2.12% | +51.27% | -12.59% | 9.98TCr | |
| +0.36% | +1.22% | +39.97% | +74.54% | 3.26TCr | |
| -0.46% | +4.73% | -10.99% | +17.50% | 2.42TCr | |
| +0.74% | +7.57% | +13.44% | +7.61% | 2.25TCr | |
| -0.40% | +8.63% | +24.94% | +28.09% | 2.11TCr | |
| -2.27% | -2.22% | +48.18% | +280.32% | 1.73TCr | |
| -0.17% | -2.28% | +50.81% | +54.04% | 1.65TCr | |
| -2.11% | -3.45% | +8.60% | +35.16% | 1.25TCr | |
| Average | -1.09% | +2.41% | +30.08% | +59.04% | 3.59TCr | |
| Weighted average by Cap. | -2.01% | +0.49% | +40.15% | +48.39% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 564.8Cr 486.91Cr 453.28Cr 421.98Cr 785.69Cr 51TCr 845.33Cr 5.21TCr 2.06TCr 24TCr 2.12TCr 2.07TCr 89TCr | 600.22Cr 517.45Cr 481.71Cr 448.45Cr 834.96Cr 54TCr 898.35Cr 5.54TCr 2.18TCr 26TCr 2.25TCr 2.2TCr 95TCr |
| Net income | 21Cr 18Cr 17Cr 16Cr 29Cr 1.9TCr 31Cr 193.16Cr 76Cr 905.58Cr 78Cr 77Cr 3.31TCr | 23Cr 20Cr 19Cr 18Cr 33Cr 2.13TCr 35Cr 216.45Cr 85Cr 1.01TCr 88Cr 86Cr 3.71TCr |
| Net Debt | 74Cr 63Cr 59Cr 55Cr 102.32Cr 6.67TCr 110.09Cr 679.02Cr 267.74Cr 3.18TCr 275.84Cr 270.16Cr 12TCr | 55Cr 47Cr 44Cr 41Cr 76Cr 4.95TCr 82Cr 503.4Cr 198.5Cr 2.36TCr 204.49Cr 200.29Cr 8.62TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/26/16 | 36.03 $ | -0.22% | 15,29,873 |
| 15/26/15 | 36.11 $ | +1.69% | 18,23,453 |
| 14/26/14 | 35.51 $ | +2.19% | 25,46,383 |
| 13/26/13 | 34.75 $ | +8.39% | 53,66,476 |
| 12/26/12 | 32.06 $ | +0.82% | 15,17,727 |
Delayed Quote Nasdaq, January 17, 2026 at 02:30 am IST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- OPCH Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition